S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
The Modernizing Government Technology Reform Act requires federal agencies to identify and report high-risk legacy information technology systems to the Federal Chief Information Officer. The Federal CIO must then compile and prioritize a list of the top 10 critical systems needing modernization, reporting this to Congress annually. Agencies can use dedicated fund money to upgrade outdated systems, enhance cybersecurity, or improve efficiency, but must repay funds to maintain the fund's operational balance until 2032. The bill also prohibits funding for projects with fraudulent or misleading information about technical design, business cases, or project management.
This bill requires the Secretaries of Defense and Veterans Affairs to evaluate existing research on menopause, perimenopause, and mid-life health for women serving in the military or who are veterans. It directs them to identify gaps in knowledge about treatments for symptoms, the impact of military service (including combat exposure and toxins like PFAS), and the availability of care and training for healthcare providers. Within 180 days of enactment, the departments must submit a report and strategic plan to Congress detailing findings and outlining steps to address research gaps and improve care. The law directly affects military women, veterans, and their healthcare providers by aiming to enhance understanding and services for menopause-related health issues.
S 654 establishes a new External Provider Scheduling Program within the Department of Veterans Affairs (VA) to improve appointment scheduling for veterans using the Veterans Community Care Program. The program requires real-time technology allowing VA schedulers to view and book appointments with community care providers, directly affecting veterans who rely on non-VA care due to VA wait times. Key provisions mandate reducing referral-to-appointment wait times (measured in days) and scheduler processing time (days/hours), with full VA medical center implementation required by September 30, 2025. The VA must also submit annual progress reports to Congress through 2028.
This bill establishes a $50 million annual federal fund to support transportation infrastructure for U.S. cities hosting major international sporting events like the Olympics, Paralympics, or FIFA World Cup. It provides grants to eligible entities - including host cities, nearby jurisdictions within 100 miles, and transportation agencies - to fund permanent transportation projects (e.g., road improvements, transit upgrades) that aid event logistics or mitigate traffic impacts, but excludes temporary event infrastructure or bid preparation costs. Assistance is limited to the 5-year period before an event begins through 30 days after it ends. The bill directly affects communities selected to host these events and their surrounding regions, ensuring federal support for sustainable transportation planning tied to the events.
HR 6093, the Agricultural Cooperative Energy Savings Act of 2025, expands eligibility for certain USDA programs to include agricultural cooperatives with fewer than 2,500 employees. This change directly affects smaller agricultural cooperatives that previously did not qualify under existing rules. The bill amends Section 9007(c)(1)(A)(i) of the Farm Security and Rural Investment Act of 2002 to add these cooperatives to the list of eligible participants. The key mechanism is simply broadening the definition of qualifying entities for existing USDA program access. This is a procedural change to eligibility criteria, not a new program.
HR 5633, the Agriculture Infrastructure Stability Act of 2025, requires the Federal Crop Insurance Corporation to develop and make available a new revenue protection policy for farmers. Specifically, it mandates the Corporation conduct research on "harvest incentive policies" covering revenue loss from harvest issues and make this policy available within two years of the law's enactment, if certain requirements are met. The bill also requires the Corporation to submit a report to congressional committees within one year detailing the research results and the policy details. This directly affects farmers participating in federal crop insurance programs by potentially providing new coverage for revenue losses tied to harvest conditions.
This bill establishes the "Expanding Childcare in Rural America Initiative" under the USDA, directing the Secretary of Agriculture to prioritize funding through six existing USDA programs (like rural business grants and essential community facilities loans) for projects addressing childcare availability, quality, or cost in rural and agricultural communities. It specifically prioritizes applications from providers in farming-dependent counties (using USDA 2015 county typology) and requires balanced geographic distribution of funds across rural areas. The initiative runs from fiscal years 2026 through 2030, with the USDA required to evaluate outcomes and report findings to Congress within three years. It directly affects rural childcare providers, families in underserved communities, and existing USDA grant programs.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
This bill denies immigration benefits to individuals who participated in, supported, or facilitated Hamas attacks against Israel starting October 7, 2023. It amends immigration law to make such individuals inadmissible (barred from entering the U.S.) and ineligible for any immigration relief, including asylum or other protections. The law requires annual reports from the Homeland Security Secretary tracking how many people are denied entry or removed under these provisions. It directly affects non-U.S. nationals involved in Hamas-related violence against Israel since the October 7, 2023, attacks.
Unauthorized Spending Accountability Act This bill reduces budgetary levels for certain federal programs that are funded through the annual appropriations process and do not have an authorization of appropriations. Under the bill, budgetary levels are spending allocations provided to the congressional appropriations committees by a congressional budget resolution or a deeming resolution. The allocations are provided under the Congressional Budget Act of 1974 and are often referred to as 302(a) allocations. The bill applies to programs included in the Congressional Budget Office's (CBO's) annual report listing programs that are funded through the appropriations process and have an authorization of appropriations that has either expired or will expire during the year. If a program is listed in the CBO report, the bill requires specified reductions to be implemented over a three-year period and terminates the unauthorized programs at the end of the third unauthorized year.
HCONRES 58 is a symbolic congressional resolution denouncing socialism in all its forms. It does not create new laws or affect any policies, as it is a non-binding statement of opinion. The resolution cites historical events and quotes from Founding Fathers to argue that socialism leads to authoritarianism and economic harm, referencing examples like the Soviet Union and Venezuela. It formally "denounces" socialism and opposes implementing socialist policies in the U.S., but has no legal effect on citizens or government actions. This is a procedural resolution, not a policy measure.
